09:01 AM EDT, 08/14/2025 (MT Newswires) -- Health care stocks were declining premarket Thursday, with the Health Care Select Sector SPDR Fund (XLV) 0.2% lower and the iShares Biotechnology ETF (IBB) down 0.7%.

Schrodinger (SDGR) stock was down more than 17% after the company said it has discontinued its program for SGR-2921, which was intended to treat relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes.